• Explore /
  • Poster
  • / Activity of regorafenib in patients with non-adipocytic soft tissue sarcoma (NASTS): Evaluation of heterogeneity of treatment effect on the updated analysis of pooled cohorts.

Activity of regorafenib in patients with non-adipocytic soft tissue sarcoma (NASTS): Evaluation of heterogeneity of treatment effect on the updated analysis of pooled cohorts.

Abstract Poster

Authors

null

Marie-Cecile Le Deley

Centre Oscar Lambret, Lille, France

Marie-Cecile Le Deley , Jean-Yves Blay , Jennifer Wallet , Francois Bertucci , Emmanuelle Bompas , Thomas Brodowicz , Loic Chaigneau , Christine Chevreau , Emilie Decoupigny , Antoine Italiano , Bernadette Lieg-Atzwanger , Olivier Mir , Sophie Piperno-Neumann , Julien Thery , Axel Le Cesne , Nicolas Penel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT01900743

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 11555)

DOI

10.1200/JCO.2022.40.16_suppl.11555

Abstract #

11555

Poster Bd #

459

Abstract Disclosures

Similar Posters

First Author: Nicolas Penel

First Author: Stephanie Clisant

First Author: Robin Lewis Jones

First Author: Samer Salah